( Jan 4th 2019 Rating Increase )
https://www.fairfieldcurrent.com/news/2019/01/04/cancer-genetics-cgix-rating-increased-to-hold-at-valuengine.html
ClayTrader Fri 01_04_2019
https://claytrader.com/stock_chart/CGIX/?utm_source=social&utm_medium=ihub&utm_campaign=chart
Just Great Videos about Cancer Genetics,Inc Nasdaq CGIX
https://www.youtube.com/embed/qyChgqJtz94
https://www.youtube.com/embed/bfwhfnBDD1c
Am Bull Dot Come Thursday BUY Rating, Friday STAY LONG Rating
https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=CGIX
Predict Wall Street 100% BUY for Monday and Next week
https://www.predictwallstreet.com/PredictNow.aspx?symbol=cgix
" Thomson Reuters/Verus upgrades CANCER GENETICS INC from SELL to HOLD.
BY Investars Analyst Actions - public
— 2:10 AM ET 12/31/2018 "
CGIX
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM